NFKB1 and metabolic dysfunction-associated steatotic liver disease: The molecular mechanisms by which FXR protects the liver from developing NAFLD are related not only to its role in regulating lipid metabolism but also in suppressing liver inflammation cascade: In particular, FXR exerts its anti-inflammatory effects via antagonizing NF-κB function and inducing acute phase response proteins [96,97].